NL7306986A - - Google Patents

Info

Publication number
NL7306986A
NL7306986A NL7306986A NL7306986A NL7306986A NL 7306986 A NL7306986 A NL 7306986A NL 7306986 A NL7306986 A NL 7306986A NL 7306986 A NL7306986 A NL 7306986A NL 7306986 A NL7306986 A NL 7306986A
Authority
NL
Netherlands
Application number
NL7306986A
Other versions
NL163428B (nl
NL163428C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7306986A publication Critical patent/NL7306986A/xx
Publication of NL163428B publication Critical patent/NL163428B/xx
Application granted granted Critical
Publication of NL163428C publication Critical patent/NL163428C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175Canine distemper virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10LSPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00Speech recognition
    • G10L15/22Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/818Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL7306986.A 1972-05-26 1973-05-18 Werkwijze voor het bereiden van een voor intraveneuze toediening geschikt combinatie-vaccin tegen honde- -ziekte en honde-hepatitis. NL163428C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (3)

Publication Number Publication Date
NL7306986A true NL7306986A (ru) 1973-11-28
NL163428B NL163428B (nl) 1980-04-15
NL163428C NL163428C (nl) 1980-09-15

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7306986.A NL163428C (nl) 1972-05-26 1973-05-18 Werkwijze voor het bereiden van een voor intraveneuze toediening geschikt combinatie-vaccin tegen honde- -ziekte en honde-hepatitis.

Country Status (13)

Country Link
US (1) US3886270A (ru)
AR (1) AR201193A1 (ru)
AT (1) AT336779B (ru)
AU (1) AU467451B2 (ru)
BE (1) BE800132A (ru)
CA (1) CA1020461A (ru)
DE (1) DE2225548C3 (ru)
DK (1) DK141055C (ru)
FR (1) FR2189023B1 (ru)
GB (1) GB1437006A (ru)
NL (1) NL163428C (ru)
SE (1) SE7608007L (ru)
ZA (1) ZA733571B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
AR201193A1 (es) 1975-02-21
DK141055C (da) 1980-06-23
ZA733571B (en) 1974-04-24
NL163428B (nl) 1980-04-15
DE2225548C3 (de) 1980-05-29
NL163428C (nl) 1980-09-15
BE800132A (fr) 1973-11-28
CA1020461A (en) 1977-11-08
FR2189023A1 (ru) 1974-01-25
AT336779B (de) 1977-05-25
US3886270A (en) 1975-05-27
AU467451B2 (en) 1975-12-04
DK141055B (da) 1979-12-31
AU5612573A (en) 1974-11-28
DE2225548B2 (de) 1979-09-06
DE2225548A1 (de) 1973-12-06
ATA459273A (de) 1976-09-15
GB1437006A (en) 1976-05-26
FR2189023B1 (ru) 1976-12-03
SE7608007L (sv) 1976-07-13

Similar Documents

Publication Publication Date Title
FR2189023B1 (ru)
FR2190951B1 (ru)
JPS523532Y2 (ru)
JPS4899142A (ru)
JPS4973872A (ru)
CH578503A5 (ru)
BG22072A3 (ru)
CH581071A5 (ru)
CH579538A5 (ru)
CH582986A5 (ru)
CH583094A5 (ru)
BG18106A1 (ru)
BG18059A1 (ru)
CH584416A5 (ru)
CH582166A5 (ru)
CH585157A5 (ru)
BG18499A1 (ru)
CH579074A5 (ru)
BG18024A1 (ru)
CH572351A5 (ru)
CH585163A5 (ru)
CH579020A5 (ru)
CH572651A5 (ru)
CH578487A5 (ru)
CH578485A5 (ru)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee